COUGAR-02

NCT00978549 📎

Regimen

Experimental
docetaxel 75 mg/m2 Q3W + active symptom control
Control
active symptom control alone

Population

Platinum/fluoropyrimidine-refractory oesophagogastric adenocarcinoma

Key finding

mOS 5.2 vs 3.6 mo (HR 0.67, 95% CI 0.49-0.92, p=0.01); improved symptom control (pain, nausea)

Source: PMID 24332238

Timeline

    Guideline citations

    • NCCN GASTRIC (p.46)